EquityZen Growth Technology Fund LLC - Series 229
Raised
$252K
Investors
5
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 229 is a Delaware-domiciled pooled investment fund that raised $252K from 5 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $10K minimum investment. Filed April 11, 2018, by EquityZen Advisors and Assure Fund Management II, this is one of approximately 1,891 related entities in the EquityZen pre-IPO platform ecosystem.
This pre-IPO vehicle follows a standard emerging growth access model with a relatively low $10K minimum, making private company exposure available to accredited investors below institutional thresholds. The 506(b)/3(c)(1) exemption pairing and series structure are consistent with EquityZen's platform approach to segmenting individual pre-IPO company positions into discrete SPVs.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
